| Amir N Cheema, MD | |
|
101 W University Ave, Champaign, IL 61820-3909 | |
| (217) 366-1304 | |
| (217) 366-7427 |
| Full Name | Amir N Cheema |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 29 Years |
| Location | 101 W University Ave, Champaign, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386707750 | NPI | - | NPPES |
| CA3360 | Other | IL | RAILROAD |
| P00376396 | Other | IL | RAILROAD |
| 036116894 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 036-116894 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christie Clinic, Llc | 7719899319 | 200 |
News Archive
Washington Post columnist Courtland Milloy on Wednesday examined PreventionWorks! - a privately funded needle-exchange program in Washington, D.C., that aims to curb the spread of HIV among injection drug users in the city.
In a study of more than 8,000 veterans living in Hawaii and the Pacific Islands, those with posttraumatic stress disorder had a nearly 50 percent greater risk of developing heart failure over about a seven-year follow-up period, compared with their non-PTSD peers.
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
› Verified 4 days ago
| Entity Name | Christie Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871523829 PECOS PAC ID: 7719899319 Enrollment ID: O20031103000332 |
News Archive
Washington Post columnist Courtland Milloy on Wednesday examined PreventionWorks! - a privately funded needle-exchange program in Washington, D.C., that aims to curb the spread of HIV among injection drug users in the city.
In a study of more than 8,000 veterans living in Hawaii and the Pacific Islands, those with posttraumatic stress disorder had a nearly 50 percent greater risk of developing heart failure over about a seven-year follow-up period, compared with their non-PTSD peers.
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
› Verified 4 days ago
| Entity Name | Salem Township Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295739548 PECOS PAC ID: 0840195277 Enrollment ID: O20031126000688 |
News Archive
Washington Post columnist Courtland Milloy on Wednesday examined PreventionWorks! - a privately funded needle-exchange program in Washington, D.C., that aims to curb the spread of HIV among injection drug users in the city.
In a study of more than 8,000 veterans living in Hawaii and the Pacific Islands, those with posttraumatic stress disorder had a nearly 50 percent greater risk of developing heart failure over about a seven-year follow-up period, compared with their non-PTSD peers.
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
› Verified 4 days ago
| Entity Name | St Anthony's Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306800602 PECOS PAC ID: 2365341211 Enrollment ID: O20040108000741 |
News Archive
Washington Post columnist Courtland Milloy on Wednesday examined PreventionWorks! - a privately funded needle-exchange program in Washington, D.C., that aims to curb the spread of HIV among injection drug users in the city.
In a study of more than 8,000 veterans living in Hawaii and the Pacific Islands, those with posttraumatic stress disorder had a nearly 50 percent greater risk of developing heart failure over about a seven-year follow-up period, compared with their non-PTSD peers.
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amir N Cheema, MD 101 W University Ave, Champaign, IL 61820-3909 Ph: (217) 366-1304 | Amir N Cheema, MD 101 W University Ave, Champaign, IL 61820-3909 Ph: (217) 366-1304 |
News Archive
Washington Post columnist Courtland Milloy on Wednesday examined PreventionWorks! - a privately funded needle-exchange program in Washington, D.C., that aims to curb the spread of HIV among injection drug users in the city.
In a study of more than 8,000 veterans living in Hawaii and the Pacific Islands, those with posttraumatic stress disorder had a nearly 50 percent greater risk of developing heart failure over about a seven-year follow-up period, compared with their non-PTSD peers.
Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
› Verified 4 days ago
Sarah Lovinger, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 Curtis Rd, Champaign, IL 61822 Phone: 217-365-6207 Fax: 217-365-6380 | |
Esha Patel, MD,MHA Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1050 Baytowne Dr Apt 24, Champaign, IL 61822 Phone: -- | |
Dr. Davendra P. Ramkumar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-6212 | |
Mr. Jason Trager, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1304 | |
Dr. Yasser Ali Haider, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1801 W Windsor Rd, Champaign, IL 61822 Phone: 217-366-1372 | |
Dr. Andrew J. Bartlett, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1801 W Windsor Rd, Champaign, IL 61822 Phone: 217-366-5434 Fax: 217-366-8074 | |
Amanda Walker, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 Curtis Rd, Adult Medicine, Champaign, IL 61822 Phone: 217-365-6207 Fax: 217-365-6380 |